New drug cocktail shows promise for tough head and neck cancers
Disease control
Completed
This study tested a combination of two drugs, duvelisib and docetaxel, in 26 people with head and neck cancer that had returned or spread and could not be cured. The goal was to see if the combo could shrink tumors. The trial was completed, and results help guide future treatment…
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated May 02, 2026 16:46 UTC